ZCI
DXCM icon

Zevenbergen Capital Investments’s DexCom DXCM Stock Holding History

Zevenbergen Capital Investments’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-685,433
Closed -$46.1M – 108
2025
Q3 		$46.1M Buy
685,433
+62,098
+10% +$4.91M 0.9% 32
2025
Q2 		$54.4M Buy
623,335
+101,782
+20% +$7.98M 1.06% 28
2025
Q1 		$35.6M Buy
521,553
+134,385
+35% +$11M 0.87% 29
2024
Q4 		$30.1M Buy
387,168
+34,020
+10% +$2.52M 0.61% 34
2024
Q3 		$23.7M Buy
+353,148
New +$29M 0.5% 39
2017
Q3 		– Sell
-3,286,640
Closed -$60.1M – 81
2017
Q2 		$60.1M Buy
3,286,640
+598,040
+22% +$11M 2.61% 17
2017
Q1 		$57M Sell
2,688,600
-47,460
-2% -$926K 2.62% 15
2016
Q4 		$40.8M Buy
2,736,060
+603,120
+28% +$10.7M 1.92% 20
2016
Q3 		$46.7M Buy
2,132,940
+133,440
+7% +$2.97M 1.92% 20
2016
Q2 		$39.7M Buy
1,999,500
+886,740
+80% +$15.1M 1.86% 23
2016
Q1 		$18.9M Buy
+1,112,760
New +$18.6M 0.86% 36

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Zevenbergen Capital Investments's DXCM Position: Q4 2025 in Review

Zevenbergen Capital Investments sold out of DexCom (DXCM) in Q4 2025, closing a stake of 685,433 shares — an estimated $46.1M sold.

Zevenbergen Capital Investments first reported a position in DXCM in Q1 2016 and held it in 11 quarters. The position peaked at $60.1M in Q2 2017. 921 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Zevenbergen Capital Investments reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Zevenbergen Capital Investments sold 685,433 DexCom shares in Q4 2025, an estimated $46.1M.
  • Zevenbergen Capital Investments first reported a position in DexCom in Q1 2016 and held it in 11 quarters.
  • Zevenbergen Capital Investments's DexCom position peaked at $60.1M in Q2 2017.
  • 921 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Zevenbergen Capital Investments's 13F filing for Q4 2025, filed 15 Jan 2026.